High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: Quantitative and qualitative analysis

Radiology

Volumn 262, Issue 2, 2012, Pages 511-519

  Agnello, Francesco ^a   Ronot, Maxime ^a,b   Valla, Dominique C ^a,b   Sinkus, Ralph ^b   Van Beers, Bernard E ^a,b   Vilgrain, Valeŕie ^a,b  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER ADENOMA; LIVER BIOPSY; LIVER FOCAL NODULAR HYPERPLASIA; LIVER INJURY; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADULT; AGED; ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84857423105     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110922     Document Type: Article

References (32)

1. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008;48(1):163-170. (Pubitemid 350199576)
2. Herman P, Pugliese V, Machado MA, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000;24(3):372-376. (Pubitemid 30117769)
3. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19(1):13-18.
4. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46(3):740-748. (Pubitemid 47436120)
5. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43(3):515-524.
6. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50(2):481-489.
7. Bioulac-Sage P, Rebouissou S, Sa Cunha A, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005;128(5):1211-1218. (Pubitemid 40712173)
8. Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation . Hepatology 2007;46(1):140-146. (Pubitemid 47171930)
9. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009;457(7226):200-204.
10. Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137(5):1698-1705.
11. Marin D, Brancatelli G, Federle MP, et al. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media. Clin Radiol 2008;63(5):577-585.
12. Mortelé KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 2000;175(3):687-692.
13. Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Sahani DV. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. Radiology 2011;258(3):673-693.
14. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 2006;58(2):236-245.
15. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;48(3):808-818.
16. Grazioli L, Morana G, Federle MP, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221(3):731-739. (Pubitemid 33101765)
17. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236(1):166-177. (Pubitemid 40853309)
18. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary- specific MR contrast agents: role in imaging the liver and biliary tree. RadioGraphics 2009;29(6):1725-1748.
19. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOBDTPA- enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008;43(7):504-511.
20. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635. (Pubitemid 46866868)
21. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted wholebody imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008;18(9):1937-1952.
22. Padhani AR, Liu G, Koh DM, et al. Diffusionweighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations . Neoplasia 2009;11(2):102-125.
23. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246(3):812-822.
24. Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications . RadioGraphics 2009;29(6):1797-1810.
25. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254(1): 47-66.
26. Kandpal H, Sharma R, Madhusudhan KS, Kapoor KS. Respiratory-triggered versus breath-hold diffusion-weighted MRI of liver lesions: comparison of image quality and apparent diffusion coefficient values. AJR Am J Roentgenol 2009;192(4):915-922.
27. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18(3):477-485. (Pubitemid 351248179)
28. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echoplanar MR imaging sequences: prospective study in 66 patients. Radiology 2003;226(1): 71-78. (Pubitemid 36163910)
29. Vossen JA, Buijs M, Liapi E, Eng J, Bluemke DA, Kamel IR. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. J Comput Assist Tomogr 2008;32(5):750-756.
30. Couinaud C. Anatomic principles of left and right regulated hepatectomy: technics [in French]. J Chir (Paris) 1954;70(12):933-966.
31. Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001;26(2): 161-165. (Pubitemid 32187120)
32. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007;46(3):521-527. (Pubitemid 46201719)